Výsledky vyhledávání - "Monkez M Yousif"

Impact of successful HCV treatment using direct acting antivirals on recurrence of well ablated hepatocellular carcinoma

Autor: Wahid Doss, Wafaa El-Akel, Imam Waked, Mohamed Hassany, Ashraf Omar Abdelaziz, Mohamed Shaker, Gamal Esmat, Tamer Elbaz, Samy Zaky, Mahmoud El-Bendary, Mohamed AbdAllah, Monkez M Yousif

Publikováno v: Expert review of anti-infective therapy. 20(2)

There are many contradictory studies that dealt with hepatocellular carcinoma (HCC) recurrence rate of well ablated hepatitis C virus (HCV) related HCC. We aim to assess the recurrence rate of previously ablated HCC in patients who received direct ac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53138012ae7bda5ffb3ed6df6a9b2db7
https://pubmed.ncbi.nlm.nih.gov/34253123

Zobrazit plný text záznamu

Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment

Autor: Josep Gregori, Josep Quer, Leonardo Nieto-Aponte, Damir Garcia-Cehic, Noha M. Hammad, Fatma A. Amer, Francisco Rodriguez-Frias, Juan Ignacio Esteban, Ariadna Rando-Segura, Monkez M Yousif

Publikováno v: Infection and Drug Resistance. 12:2799-2807

Purpose To study resistance-associated substitutions using next-generation sequencing in Egyptian hepatitis C virus-infected patients failing direct-acting antiviral treatment. Methods The current study describes three cases of treatment failure in p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::64633d21397ee899dbab89bd3c49130b
https://doi.org/10.2147/idr.s214735

Zobrazit plný text záznamu

Associated vitamin D deficiency is a risk factor for the complication of HCV-related liver cirrhosis including hepatic encephalopathy and spontaneous bacterial peritonitis

Autor: Hesham A Farrag, Ayman M. E. M. Sadek, Rasha I. Salama, Monkez M Yousif, Fayrouz Othman Selim, Emad F Hamed

Publikováno v: Internal and Emergency Medicine. 14:753-761

The influence of vitamin D, 25-hydroxyvitamin D (25(OH)D), deficiency on hepatitis C virus (HCV)-related cirrhosis had been poorly elucidated especially in patients with hepatic encephalopathy (HE) and spontaneous bacterial peritonitis (SBP). We aime

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f79a5dcfc5f0d83f1e5e58446904895b
https://doi.org/10.1007/s11739-019-02042-2

Zobrazit plný text záznamu

Impact of Apo Lipoprotein E Gene Polymorphism on Hepatitis C Virus Disease Progression and Response to Direct Acting Antivirals in the Egyptian Population

Autor: Ahmed Elsadek Fakhr, Ayaat Mohamed Zedan, Fayrouz Othman Selim, Monkez M Yousif, Ghada Mohamed Samir

Publikováno v: Hepatitis Monthly. 20

Background: Hepatitis C virus infection is a major health problem in Egypt. Apo lipoprotein E and lipid metabolism are closely associated with the life cycle of the virus and play an important role in facilitating this infection. Objectives: To ident

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a5f26d3d832856e9d4c955c9ad8fab0b
https://doi.org/10.5812/hepatmon.101516

Zobrazit plný text záznamu

Real-world safety and effectiveness of retreatment of Egyptian chronic hepatitis C patients not responding to NS5A inhibitor-based therapies

Autor: Hany M Elsadek, Islam A. Elsayed, Ayman M. Zaki, Mahmoud H Zahran, Hussien Ahmed, Mohamed Gendia, Monkez M Yousif, Hamdy Shafeik, Mahmoud Magdy, Nevin F. lbrahim, Ayman M. E. M. Sadek, Ali M Shendi, Tamer M. Gouda

Publikováno v: Journal of viral hepatitisREFERENCES. 27(11)

The aim of this study was to assess the efficacy and safety of two protocols for retreatment of a cohort of Egyptian patients with chronic hepatitis C (CHC) who relapsed after NS5A inhibitor-based therapy. We conducted a prospective cohort study to a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::864de7b4e4b1e4c970abcbfd2508fc43
https://pubmed.ncbi.nlm.nih.gov/32564500

Zobrazit plný text záznamu

Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in Egypt

Autor: Tamer Elbaz, A. Nasr, Mohamed AbdAllah, Wahid Doss, W. El Akel, Y. El Shazly, Mohammed Shaker, Ahmed A. Gomaa, Imam Waked, Mohd Shahrir Mohamed Said, Sohier Ahmed Ismail, Gamal Esmat, H. El Shazly, M. El Kassas, Mohamed Korany, Kadry Elsaeed, Heba Omar, Monkez M Yousif

Publikováno v: Alimentary Pharmacology & Therapeutics. 47:421-431

SummaryBackground Treatment of chronic hepatitis C using combination of sofosbuvir (SOF) and daclatasvir (DCV) was used in several clinical trials and multicentre studies, which were somewhat limited to genotypes 1-3. The national program in Egypt is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09c6d870d49f38ad947d516578c64734
https://doi.org/10.1111/apt.14428

Zobrazit plný text záznamu

INTERLEUKIN 28B GENE POLYMORPHISMS AS A PREDICTOR OF TREATMENT RESPONSE IN EGYPTIANS WITH CHRONIC HEPATITIS C

Autor: Osama A. Khalil, Mohammed S. Fawzi, Ahmed I. El Agrody, Monkez M Yousif

Publikováno v: Zagazig University Medical Journal. 20:1-8

Egypt has the highest prevalence of HCV all over the world with 9% countrywide and up to 42% in certain rural areas. Combined PEG-IFN and ribavirin is still the only standard of care treatment in spite of its side effects, high costs and low sustaine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a088f0cab50a933b195739ffe36ce6b8
https://doi.org/10.21608/zumj.2017.4442

Zobrazit plný text záznamu

Surveillance and impact of occult hepatitis B virus, SEN virus, and torque teno virus in Egyptian hemodialysis patients with chronic hepatitis C virus infection

Autor: Rania Abdelmonem Khattab, Heba A. Mohtady, Khan F.M. Ayaz, Fatma A. Amer, Ergenekon Karagoz, Noha M. Hammad, Monkez M Yousif

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 92

Egypt ranks first regarding the prevalence of hepatitis C virus (HCV) infection. Many patients have concomitant diseases like kidney disorders requiring hemodialysis, a procedure carrying the hazard of transmitting other hepatitis viruses. The purpos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a4d6e08e66a9c89c9392a3d6a4c704a
https://pubmed.ncbi.nlm.nih.gov/31863879

Zobrazit plný text záznamu

Prevalence of occult hepatitis C virus infection in patients who achieved sustained virologic response to direct-acting antiviral agents

Autor: Monkez M, Yousif, Ahmed, Elsadek Fakhr, Emad A, Morad, Hesham, Kelani, Emad F, Hamed, Hany M, Elsadek, Mahmoud H, Zahran, Afify, Fahmy Afify, Waleed A, Ismail, Ahmed I, Elagrody, Nevin F, Ibrahim, Fatma A, Amer, Ayman M, Zaki, Ayman M E M, Sadek, Ali M, Shendi, George, Emad, Hesham A, Farrag

Publikováno v: Le infezioni in medicina. 26(3)

The reappearance of HCV infection months or years after sustained virologic response (SVR) may be due to the persistence of HCV in tissue cells in spite of being undetected in serum. This situation is known as occult hepatitis C infection (OCI). We a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bbd475479ec2a369189b01452f95be2e
https://pubmed.ncbi.nlm.nih.gov/30246766

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání